FDA Clears PENS Device for Pain Related to Diabetic Peripheral Neuropathy
First Relief is a wearable PENS device that is placed behind the ear.
First Relief is a wearable PENS device that is placed behind the ear.
Several pharmacotherapies have been shown to reduce pain in patients with painful diabetic neuropathy.
The American Society of Pain and Neuroscience has published a best practice guideline for the management and reduction of cancer-associated pain.
The researchers performed a systematic review and meta-analyses to determine if epidural steroid injections result in clinically meaningful improvement in lumbosacral radicular syndrome.
Opioids were prescribed to nearly 43% of patients newly diagnosed with diabetic peripheral neuropathy who were started on pain medications.
Trigeminal neuralgia is a chronic neuropathic pain disorder that is important to include in the differential diagnosis of head or facial pain.
At 1 month, no significant difference seen in positive outcomes for treatment vs control.
Investigators sought to determine the safety and efficacy of electroacupuncture for painful diabetic peripheral neuropathy.
Individuals with gluten neuropathy experienced less peripheral neuropathic pain when adhering to strict gluten-free diets.
Often underreported and undertreated, outcomes can be improved in this condition with appropriate screening and diagnosis.